Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$269.00-6.23 (-2.26%)
Delayed quote: Sep 8, 2026, 1:05 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 8, 2026, 1:05 PM EDT
Basis: latest reported fiscal quarter. Source: stored company filings; unavailable inputs remain N/A.
The latest quarterly gross profit is $18.50B with a quarterly period change of +7.56%. Gross profit is revenue minus cost of revenue, before operating expenses, interest, and taxes.
Reported quarterly gross profit; no daily interpolation.
Gross Profit growth vs the same quarter one year earlier, last 40 quarters.
1 Year
+12.09%
3 Year
+4.37%
5 Year
+4.14%
10 Year
+3.48%
15 Year
+3.14%
20 Year
+3.19%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Period | Gross Profit | % Change |
|---|---|---|
| Quarter ended Jun 2026 | $18.50B | +7.56% |
| Quarter ended Mar 2026 | $17.20B | +3.66% |
| Quarter ended Dec 2025 | $16.60B | (0.56%) |
| Quarter ended Sep 2025 | $16.69B | +3.57% |
| Quarter ended Jun 2025 | $16.11B | +10.86% |
| Quarter ended Mar 2025 | $14.54B | (5.56%) |
| Quarter ended Dec 2024 | $15.39B | (0.75%) |
| Quarter ended Sep 2024 | $15.51B | (0.45%) |
| Quarter ended Jun 2024 | $15.58B | +4.75% |
| Quarter ended Mar 2024 | $14.87B | +1.88% |
| Quarter ended Dec 2023 | $14.60B | (1.00%) |
| Quarter ended Oct 2023 | $14.74B | (2.07%) |
| Quarter ended Jul 2023 | $15.06B | +5.98% |
| Quarter ended Apr 2023 | $14.21B | (10.88%) |
| Quarter ended Dec 2022 | $15.94B | +15.31% |
| Quarter ended Oct 2022 | $13.82B | (14.14%) |
| Quarter ended Jul 2022 | $16.10B | +1.72% |
| Quarter ended Apr 2022 | $15.83B | (6.06%) |
| Quarter ended Dec 2021 | $16.85B | +4.73% |
| Quarter ended Oct 2021 | $16.09B | +2.31% |
| Quarter ended Jul 2021 | $15.72B | +3.06% |
| Quarter ended Apr 2021 | $15.26B | +4.07% |
| Quarter ended Dec 2020 | $14.66B | +3.91% |
| Quarter ended Sep 2020 | $14.11B | +20.01% |
| Quarter ended Jun 2020 | $11.76B | (13.74%) |
| Quarter ended Mar 2020 | $13.63B | +0.12% |
| Quarter ended Dec 2019 | $13.61B | (1.80%) |
| Quarter ended Sep 2019 | $13.86B | +1.76% |
| Quarter ended Jun 2019 | $13.62B | +1.61% |
| Quarter ended Mar 2019 | $13.41B | (0.20%) |
| Quarter ended Dec 2018 | $13.43B | (2.37%) |
| Quarter ended Sep 2018 | $13.76B | (1.04%) |
| Quarter ended Jul 2018 | $13.90B | +3.79% |
| Quarter ended Apr 2018 | $13.39B | +3.42% |
| Quarter ended Dec 2017 | $12.95B | +1.78% |
| Quarter ended Oct 2017 | $12.72B | (2.06%) |
| Quarter ended Jul 2017 | $12.99B | +5.15% |
| Quarter ended Apr 2017 | $12.36B | (1.71%) |
| Quarter ended Dec 2016 | $12.57B | +1.93% |
| Quarter ended Oct 2016 | $12.33B | (6.18%) |
| Quarter ended Jul 2016 | $13.15B | +8.17% |
| Quarter ended Apr 2016 | $12.15B | +0.12% |
| Quarter ended Dec 2015 | $12.14B | +2.19% |
| Quarter ended Sep 2015 | $11.88B | (4.44%) |
| Quarter ended Jun 2015 | $12.43B | +2.80% |
| Quarter ended Mar 2015 | $12.09B | (2.49%) |
| Quarter ended Dec 2014 | $12.40B | (5.10%) |
| Quarter ended Sep 2014 | $13.07B | (2.88%) |
| Quarter ended Jun 2014 | $13.46B | +6.29% |
| Quarter ended Mar 2014 | $12.66B | +2.10% |
| Quarter ended Dec 2013 | $12.40B | +1.38% |
| Quarter ended Sep 2013 | $12.23B | (1.27%) |
| Quarter ended Jun 2013 | $12.39B | +3.66% |
| Quarter ended Mar 2013 | $11.95B | +3.43% |
| Quarter ended Dec 2012 | $11.55B | +0.87% |
| Quarter ended Sep 2012 | $11.46B | +1.09% |
| Quarter ended Jul 2012 | $11.33B | +0.96% |
| Quarter ended Apr 2012 | $11.22B | +2.81% |
| Quarter ended Dec 2011 | $10.92B | (0.15%) |
| Quarter ended Oct 2011 | $10.93B | (4.31%) |
| Quarter ended Jul 2011 | $11.43B | +0.26% |
| Quarter ended Apr 2011 | $11.39B | +7.46% |
| Quarter ended Dec 2010 | $10.60B | +2.08% |
| Quarter ended Oct 2010 | $10.39B | (2.92%) |
| Quarter ended Jul 2010 | $10.70B | (3.63%) |
| Quarter ended Apr 2010 | $11.10B | (1.21%) |
| Quarter ended Dec 2009 | $11.24B | +5.56% |
| Quarter ended Sep 2009 | $10.65B | (1.32%) |
| Quarter ended Jun 2009 | $10.79B | +0.13% |
| Quarter ended Mar 2009 | $10.78B | (0.32%) |
| Quarter ended Dec 2008 | $10.81B | (3.02%) |
| Quarter ended Sep 2008 | $11.15B | (4.72%) |
| Quarter ended Jun 2008 | $11.70B | +1.03% |
| Quarter ended Mar 2008 | $11.58B | +3.18% |
| Quarter ended Dec 2007 | $11.22B | +4.93% |
| Quarter ended Sep 2007 | $10.70B | (0.71%) |
| Quarter ended Jul 2007 | $10.77B | +1.14% |
| Quarter ended Apr 2007 | $10.65B | +10.10% |
| Quarter ended Dec 2006 | $9.68B | +0.39% |
| Quarter ended Oct 2006 | $9.64B | +0.65% |
| Quarter ended Jul 2006 | $9.57B | +2.08% |
| Quarter ended Apr 2006 | $9.38B | +4.38% |
| Quarter ended Dec 2005 | $8.99B | +0.33% |
| Quarter ended Oct 2005 | $8.96B | (3.07%) |
| Quarter ended Jul 2005 | $9.24B | (1.03%) |
| Quarter ended Apr 2005 | $9.34B | +3.21% |
| Quarter ended Dec 2004 | $9.05B | +8.13% |
| Quarter ended Sep 2004 | $8.37B | +0.53% |
| Quarter ended Jun 2004 | $8.32B | +1.59% |
| Quarter ended Mar 2004 | $8.19B | +5.76% |
| Quarter ended Dec 2003 | $7.75B | +3.63% |
| Quarter ended Sep 2003 | $7.47B | +1.48% |
| Quarter ended Jun 2003 | $7.37B | +3.76% |
| Quarter ended Mar 2003 | $7.10B | +7.46% |
| Quarter ended Dec 2002 | $6.61B | +2.13% |
| Quarter ended Sep 2002 | $6.47B | N/A |